ACC.22: Medtronic Renal Denervation System Demonstrates Significant BP Reduction Through 3 Years

ACC.22: Medtronic adds to its robust clinical program with long-term data demonstrating the continued blood pressure lowering effect of the Symplicity renal denervation procedure. Also completes enrollment in the SPYRAL HTN-ON MED trial.

Continue ReadingACC.22: Medtronic Renal Denervation System Demonstrates Significant BP Reduction Through 3 Years